Edition:
United Kingdom

ReproCell Inc (4978.T)

4978.T on Tokyo Stock Exchange

190JPY
16 Aug 2018
Change (% chg)

¥-6 (-3.06%)
Prev Close
¥196
Open
¥193
Day's High
¥194
Day's Low
¥189
Volume
430,100
Avg. Vol
526,951
52-wk High
¥412
52-wk Low
¥189

Latest Key Developments (Source: Significant Developments)

ReproCell says exercise of options
Monday, 23 Jul 2018 

July 23(Reuters) - ReproCell Inc <4978.T>:Says 1 million units of its 14th series options were exercised to 1 million shares of its common stock from July 12 to July 23.  Full Article

ReproCell says exercise of options
Wednesday, 11 Jul 2018 

July 11 (Reuters) - ReproCell Inc <4978.T> ::Says 1.1 million units of its 14th series options were exercised to 1.1 million shares of its common stock from July 2 to July 11.  Full Article

ReproCELL plans JV with Q Therapeutics Inc
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - ReproCELL Inc <4978.T> ::Says it reaches agreement to set up a joint venture with US-based firm Q Therapeutics Inc, which is mainly engaged in development of regenerative medicine products.New JV will be mainly engaged in joint research on iPS cells regenerative medicine products for patient with diseases of the central nervous system .  Full Article

ReproCell announces exercise of options
Thursday, 25 May 2017 

May 25(Reuters) - ReproCell Inc <4978.T>:Says 600 of its 12th series options were exercised to 600,000 shares as of May 25.  Full Article

ReproCell says exercise of warrants
Tuesday, 14 Feb 2017 

ReproCell Inc <4978.T>:Says 630 of its 12th series warrants were exercised into 630,000 shares, during the period from Feb. 1 to Feb. 14.  Full Article

BRIEF-ReproCell buys 98.3 pct stake in Bioserve Biotechnologies India for $1.96 mln

* Says it buys 1.3 million shares (98.3 percent stake)of Bioserve Biotechnologies India Pvt. Ltd from Cancer Genetics Inc for $1.96 million(213.2 million yen) in total, on April 26